Biomedical Engineering Reference
In-Depth Information
References
Amaldoss W, He C (2009) Direct-to-consumer advertising of prescription drugs: a strategic analysis.
Mark Sci 28(3):472-487
Bala R, Bhardwaj P (2010) Detailing vs direct-to-consumer advertising in the prescription pharma-
ceutical industry. Manage Sci 56(1):148-60
Berndt ER (2005) To inform or persuade? Direct-to-consumer advertising of prescription drugs. N
Engl J Med 352(4):325-328
Bradford WD, Kleit AN, Nietert PJ, Ornstein S (2010) The effect of direct to consumer television
advertising on the timing of the treatment. Econ Inq 48(2):306-322
Calfee J, Winston C, Stempski R (2002) Direct-to-consumer advertising and the demand for
cholesterol-reducing drugs. J Law Econ 45(2):673-690
Capella ML, Taylor CR, Campbell RC, Longwell LS (2009) Do pharmaceutical marketing activi-
ties raise prices? Evidence from five major therapeutic classes. J Public Policy Mark
28(2):146-161
Chandukala SR, Dotson JP, Brazell JD, Allenby GM (2011) Bayesian analysis of hierarchical
effects. Mark Sci 30(1):123-133
Cox AD, Cox D, Mantel SP (2010) Consumer response to drug risk information: the role of posi-
tive affect. J Mark 74(4):31-44
Donohue JM, Berndt ER (2004) Effects of direct-to-consumer advertising on medication choice:
the case of antidepressants. J Public Policy Mark 23(2):115-127
Donohue JM, Cevasco M, Rosenthal MB (2007) A decade of direct-to-consumer advertising of
prescription drugs. N Engl J Med 357(7):673-681
Fischer M, Albers S (2010) Patient- or physician-oriented marketing: what drives primary demand
for prescription drugs? J Mark Res (JMR) 47(1):103-121
Frosch DL, Krueger PM, Hornik RC, Cronholm PF, Barg FK (2007) Creating demand for prescription
drugs: a content analysis of television direct-to-consumer advertising. Ann Fam Med 5(1):6-13
Gellad ZF, Lyles KW (2007) Direct-to-consumer advertising of pharmaceuticals. Am J Med
120(6):475-480
General Accounting Office (2002) Prescription drugs: FDA oversight of direct-to-consumer adver-
tising has limitations. United States General Accounting Office, Washington, DC
IMS Health (2011) 2010 U.S. spending and prescription information. http://www.imshealth.com/
portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=ed2e5a6b
5895f210VgnVCM100000ed152ca2RCRD&cpsextcurrchannel=1 . Accessed 15 May 2011
Health Canada (January, 1996) The distinction between advertising and other activities. http://
www.hc-sc.gc.ca/dhp-mps/advert-publicit/pol/actv_promo_vs_info-eng.php . Accessed 15
May 2011
Health Canada (November, 2000) Advertising campaigns for branded and unbranded messages.
http://www.hc-sc.gc.ca/dhp-mps/advert-publicit/pol/advert-pub_camp-eng.php . Accessed 15
May 2011
Hollon MF (2005) Direct-to-consumer advertising. JAMA 293(16):2030-2033
Holmer AF (2002) Direct-to-consumer advertising—strengthening our health care system. N Engl
J Med 346(7):526-528
Iizuka T (2004) What explains the use of direct-to-consumer advertising of prescription drugs? J
Ind Econ 52(3):349-379
Iizuka T, Jin GZ (2005) The effect of prescription drug advertising on doctor visits. J Econ Manag
Strat 14(3):701-727
Iizuka T, Jin GZ (2007) Direct-to-consumer advertising and prescription choice. J Ind Econ
55(4):771
Kolsarici C, Vakratsas D (2010) Category- versus brand-level advertising messages in a highly
regulated environment. J Mark Res 47(6):1078-1089
Kremer STM, Bijmolt THA, Wieringa JE, Leeflang PSH (2008) Generalizations on the effective-
ness of pharmaceutical promotional expenditures. Int J Res Mark 25(4):234-246
Search WWH ::




Custom Search